🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9,250 results for “IO” Clear

  1. SARS-CoV-2 mRNA Vaccine

    Biotech Pharmaceutical Co.,

    COVID-19

    phase 3 mab active

    1 trial

  2. SARS-CoV-2 vaccine (inactivated)

    Sinovac Research and Development Co.,

    SARS-CoV2 Infection

    phase 3 mab completed

    1 trial

  3. SAU

    BRIGHT MINDS BIOSCIENCES INC.

    Signs and Symptoms

    phase 3 other completed

    1 trial

  4. SB-497115-GR 12.5mg

    GlaxoSmithKline

    Chronic Idiopathic Thrombocytopenic Purpura

    phase 3 small molecule completed

    1 trial

  5. SB11 (Proposed ranibizumab biosimilar)

    Samsung Bioepis NL B.V.

    Age-Related Macular Degeneration

    phase 3 small molecule completed

    1 trial

  6. SDF solution

    The University of Hong Kong

    Dental Caries

    phase 3 other completed

    1 trial

  7. SELINEXOR, Selinexor placebo for 20 mg tablets is formulated for oral administration. selinexor placebo tablets are film coated bi-convex round tablets

    Karyopharm Therapeutics Inc

    endometrial cancer

    phase 3 small molecule active

    1 trial

  8. SELPERCATINIB, CARBOPLATIN , SELPERCATINIB, PEMBROLIZUMAB, CISPLATIN , PEMETREXED

    Eli Lilly Co.

    Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  9. SER-109

    Seres Therapeutics

    Clostridioides Difficile Infection

    phase 3 mab completed

    1 trial

  10. SER-109

    Seres Therapeutics

    Clostridium Difficile Infection

    phase 3 mab completed

    1 trial

  11. SERTRALINE , LITHIUM , ESCITALOPRAM , QUETIAPINE, VENLAFAXINE , VALPROIC ACID , BUPROPION

    Disc Medicine

    Bipolar depression

    phase 3 small molecule active

    1 trial

  12. SGM-101

    BRIGHT MINDS BIOSCIENCES INC.

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  13. SGT-003

    Solid Biosciences

    Duchenne Muscular Dystrophy

    phase 3 gene therapy active

    2 trials

  14. SHP465

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    phase 3 small molecule completed

    4 trials

  15. SHP465 12.5mg capsules (one capsule daily)

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    phase 3 small molecule completed

    1 trial

  16. SKY0402

    Pacira Ireland Limited

    Bunion

    phase 3 small molecule completed

    1 trial

  17. SMC021 Oral Calcitonin

    Nordic Bioscience A/S

    Osteoarthritis

    phase 3 small molecule completed

    1 trial

  18. SMC021 Oral calcitonin

    Nordic Bioscience A/S

    Osteoporosis

    phase 3 small molecule completed

    1 trial

  19. SOC plus 15mg/kg EB05 IV

    Edesa Biotech

    COVID-19

    phase 3 mab on hold

    1 trial

  20. SODIO CLORURO 0,9% BAXTER Soluzione per infusione, KETAMINA MOLTENI 50 mg/ml soluzione iniettabile

    Talion

    Major Depressive Disorder (MDD)

    phase 3 small molecule active

    1 trial

  21. SODIO CLORURO 0,9% BAXTER Soluzione per infusione, KETAMINA MOLTENI 50 mg/ml soluzione iniettabile

    Talion

    Major Depressive Disorder (MDD)

    phase 3 small molecule active

    1 trial

  22. SODIUM CHLORIDE , CAEL-101

    Alexion Europe SAS

    Stage IIIb cardiac AL amyloidosis

    phase 3 small molecule active

    1 trial

  23. SODIUM CHLORIDE , CAEL-101

    Alexion Europe SAS

    stage IIIa cardiac AL amyloidosis

    phase 3 small molecule active

    1 trial

  24. SODIUM CHLORIDE, Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Pari Pharma GmbH

    HPV vaccine

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources